Skip to main content
Clinical Trials/NCT01278524
NCT01278524
Completed
Not Applicable

International Multicenter Study One Day Prevalence Observational Study for Delirium on ICU

Claudia Spies1 site in 1 country1,002 target enrollmentJanuary 2011
ConditionsDelirium

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delirium
Sponsor
Claudia Spies
Enrollment
1002
Locations
1
Primary Endpoint
Implementation rate of routine delirium assessment
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

An anonymous international multicenter - clinical survey, one-day observational study.

Detailed Description

Delirium is a serious complication in postoperative and critically ill patients and is independently associated with cognitive impairment at hospital discharge and with significantly higher 6-month mortality. Furthermore, ICU delirium is associated with more days requiring mechanically ventilation, longer ICU length of stay, and longer hospital length of stay. More recently a study by Pisani and co-workers' could show an association between days of delirium and mortality; - each additional day spent in delirium is associated with a 20% increased risk of prolonged hospitalization - translating to over 10 additional days - and a 10% increased risk of death.The reported prevalence of delirium in critically ill patients ranges widely from 11% to 87%. The aim of our study is to investigate the implementation rate of routine delirium assessment in European ICUs.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
January 2011
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

Claudia Spies

Prof. Dr. C. Spies, MD, Department of Anesthesiology and Intensive Care Medicine, Campus Virchow Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin

Charite University, Berlin, Germany

Eligibility Criteria

Inclusion Criteria

  • Patients staying in the ICU on the 25th of January (one-day prevalence study)
  • No exclusion Criteria:

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Implementation rate of routine delirium assessment

Time Frame: 24 hours

Secondary Outcomes

  • Point prevalence of ICU delirium(24 hours)
  • Methodology of delirium assessment (e.g. type of score, frequency of evaluation)(24 hours)
  • Non-pharmacological treatment-/prevention strategies(24 hours)
  • Drugs used for delirium treatment(24 hours)
  • Sedation practices (e.g. scales, daily sedation goals, SBT - spontaneous breathing trials, SAT - spontaneous awakening trials)(24 hours)
  • Analgesia regimes (e.g. scales)(24 hours)

Study Sites (1)

Loading locations...

Similar Trials